COMEX Silver Delivery Surge Highlights Potential Supply Tightness UK and Gulf States Finalize 37bn Trade Agreement with Tariff Reductions Global Markets Eye Potential TrumpXi Summit Outcomes as Trade Tensions Simmer Walmarts NonRetail Arm Emerges as Growth Engine but Premium Valuation Demands Proof Applied Digital Secures Major Hyperscaler Lease for Polaris Forge 3 Campus Analyst Sees Potential Upside US House Foreign Affairs Committee Chair Warns of Chinas Growing Role in Argentina Contract Bid Immunome Inc Q1 2026 Earnings NarrowerThanExpected Loss Amid No Revenue Stock Slips NWBI Q1 2026 Earnings Earnings Surpass Estimates as Stock Declines Amid Broader Market Pressure DBV Technologies Q1 2026 Earnings WiderthanExpected Loss Amidst No Revenue LCID Q1 2026 Earnings WiderThanExpected Loss Highlights Persistent Cash Burn Netcapital Inc NCPL Q1 2026 Earnings EPS Misses Estimates Amidst Challenging Operating Environment Tyra Biosciences Inc TYRA Q1 2026 Earnings WiderThanExpected Loss as Clinical Pipeline Progress Continues DSS Inc DSS Slips 136 to 05 Key Support Level in Focus Grifols GRFS Edges Lower Amid Volume Analysis Key Support Levels in Focus Lockheed Martin LMT Gains 114 as Defense Sector Momentum Continues Support and Resistance in Focus Fortress Biotech Preferred Shares FBIOP Gain 237 as Price Approaches Key Resistance Silgan Holdings SLGN Holds Steady Near Key Support as Market Sentiment Remains Neutral Pacific Biosciences PACB Edges Higher But Key Resistance Remains a Hurdle SeaStar Medical ICU Gains 195 as Stock Approaches Key Resistance Level Vantage Corp VNTG Surges 7 as Momentum Builds Toward Key Resistance K2 Capital Acquisition Corporation Rights KTWOR Hold Steady at 022 Amid Low Volume Rekor Systems REKR Faces Continued Pressure Near Key Support Level Huntington Bancshares Preferred Stock HBANM Holds Steady Amid Modest Decline Novartis Raises FullYear Sales and Profit Outlook Signaling Strong Operating Momentum BUD Q1 2026 Earnings EPS Beats Estimates by 815 Yet Shares Slip Tectonic Therapeutic TECX Rallies 376 as Biotech Momentum Builds Key Levels to Watch